glp 1 medication while breastfeeding on GLP-1: Safety & Clinical Considerations – PlexusDx semaglutide and breast feeding Safety

Biologic therapies have transformed Crohn's disease management and include several FDA-approved options: TNF- inhibitors : Infliximab (Remicade), adalimumab (Humira), and certolizumab pegol (Cimzia) block tumor necrosis factor-alpha, a key pro-inflammatory cytokine

The dose continues to increase by 2.5mg increments every four weeks, up to a maximum of 15mg per week, so long as the user can tolerate it (6)

The newest kid on the block The ATTAIN-2 trial was conducted across 10 countries and involved more than 1,600 people who were obese or overweight with type 2 diabetes

S., Alexe, A., Apara, O., et al

Arbour et al